Generation and Characterization of Mirikizumab, a Humanized Monoclonal Antibody Targeting the p19 Subunit of IL-23.
J Pharmacol Exp Ther
; 387(2): 180-187, 2023 11.
Article
in En
| MEDLINE
| ID: mdl-37714687
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Colitis, Ulcerative
/
Crohn Disease
Limits:
Animals
/
Humans
Language:
En
Journal:
J Pharmacol Exp Ther
Year:
2023
Type:
Article